FiledIssuerIndustrySold
Mar 2026Linse Capital Stellar II LPPooled Investment Fund-
Mar 2026AA Endeavor LLCPooled Investment Fund$8.0M
Mar 2026Clearmont Capital Fund LLCPooled Investment Fund$174M
Jan 2026iBio, Inc.Biotechnology$26M
Dec 2025Linse Capital AI LPPooled Investment Fund$56M
Nov 2025Aa Juul, LLCPooled Investment Fund-
Oct 2025Medalist Partners Asset-Based Private Credit Fund IV Onshore Feeder, L.P.Pooled Investment Fund-
Oct 2025Medalist Partners Asset-Based Private Credit Fund IV Offshore Feeder, L.P.Pooled Investment Fund-
Oct 2025AA Kraken, LLCPooled Investment Fund$54M
Aug 2025Emov, LLCPooled Investment Fund$38M
Aug 2025SAB Biotherapeutics, Inc.Biotechnology$175M
May 2025Linse Capital Stellar LPPooled Investment Fund$42M
Mar 2025AA 26N Private Equity Partners Access Fund LLCPooled Investment Fund-
Feb 2025Private Market Opportunity - Vista Fund VI, LLCPooled Investment Fund-
Dec 2024Alkeon Innovation Co-Invest I, LPPooled Investment Fund$12M
Dec 2024Olema Pharmaceuticals, Inc.Pharmaceuticals$250M
Oct 2024AA Millennium USA Access Fund LLCPooled Investment Fund-
Sept 2024Oaktree Power Opportunities Fund VII Feeder (Cayman), L.P.Pooled Investment Fund-
Sept 2024Oaktree Power Opportunities Fund VII, L.P.Pooled Investment Fund-
Sept 2024Oaktree Power Opportunities Fund VII Feeder 2 (Cayman), L.P.Pooled Investment Fund-
Sept 2024AA Oaktree Power7 Access Fund LLCPooled Investment Fund-
Sept 2024Linse Capital Space III LPPooled Investment Fund$40M
Aug 2024Chemomab Therapeutics Ltd.Biotechnology$10M
Jul 2024Linse Capital SKY III LPPooled Investment Fund$14M
Apr 2024Arrowroot Ironconnect, L.P.Pooled Investment Fund-
Apr 2024Linse Capital Space II LLCPooled Investment Fund$53M
Apr 2024Avalo Therapeutics, Inc.Biotechnology$131M
Mar 2024Skye Bioscience, Inc.Biotechnology$40M
Mar 2024Perspective Therapeutics, Inc.Agents: Oppenheimer & Co. Inc.Biotechnology$87M
Mar 2024Clearlane Capital Fund LLCPooled Investment Fund$146M
Feb 2024Agilitas 2024 Human Investment Fund SCSpAgents: N/APooled Investment Fund$30M
Feb 2024Skye Bioscience, Inc.Biotechnology$50M
Nov 2023Linse Capital VER II LLCPooled Investment Fund$11M
Sept 2023Cellectar Biosciences, Inc.Biotechnology$25M
Mar 2023Industry Ventures Secondary X, L.P.Pooled Investment Fund-
Jan 2023Private Market Opportunity - Vista Fund V, LLCPooled Investment Fund-
Apr 2022Trevi Therapeutics, Inc.Biotechnology$55M
Mar 2022Linse Capital Wayve LLCPooled Investment Fund$6.9M
Mar 2022Linse Capital SKY II LLCPooled Investment Fund$71M
Feb 2022Private Market Opportunity - Vista Fund IV, LLCPooled Investment Fund-
From the SEC's Form D data sets: the issuer named this firm as paid to sell the offering. The latest 40 shown.